Search Results 1571-1580 of 14760 for anti-TNF drugs

  1. Study of BIIB092 in Participants With Progressive Supranuclear Palsy - Mayo Clinic

    By condition, treatment or drug name. Search tips. Study ... [anti-HBc]). Participants with immunity to ... Treatment with any other investigational drugs ...

  2. Metoprolol (Oral Route) Precautions - Mayo Clinic

    Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines ...

  3. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    By condition, treatment or drug name ... Drugs used in chemotherapy, such as dexamethasone ... Patients who have not recovered from AEs due to prior anti ...

  4. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

    By condition, treatment or drug name ... Drugs used in chemotherapy, such as temozolomide ... anti-CTLA4 antibody; Must have experienced disease ...

  5. Estradiol (Transdermal Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... anti-PD-L1 antibody, avelumab, in selected advanced solid tumors. ... Concurrent cancer treatment with ...

  7. Crossing the Finish Line With Help From Sports Medicine - Mayo Clinic News Network

    As her physical therapy progressed, Kaitlyn transitioned out of the boot in early September 2018 and started running on an anti-gravity treadmill. "It ...

  8. Ketoconazole (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  9. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

    Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy. Print details. Share; Facebook · Twitter.

  10. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

    About this study. The primary purpose of this study is to assess the anti-tumor activity of LGX818/MEK162 in combination with targeted agents after ...